Neurological diagnoses in hospitalized COVID-19 patients associated with adverse outcomes: A multinational cohort study
Meghan R Hutch,Jiyeon Son,Trang T Le,Chuan Hong,Xuan Wang,Zahra Shakeri Hossein Abad,Michele Morris,Alba Gutiérrez-Sacristán,Jeffrey G Klann,Anastasia Spiridou,Ashley Batugo,Riccardo Bellazzi,Vincent Benoit,Clara-Lea Bonzel,William A Bryant,Lorenzo Chiudinelli,Kelly Cho,Priyam Das,Tomás González González,David A Hanauer,Darren W Henderson,Yuk-Lam Ho,Ne Hooi Will Loh,Adeline Makoudjou,Simran Makwana,Alberto Malovini,Bertrand Moal,Danielle L Mowery,Antoine Neuraz,Malarkodi Jebathilagam Samayamuthu,Fernando J Sanz Vidorreta,Emily R Schriver,Petra Schubert,Jeffery Talbert,Amelia L M Tan,Byorn W L Tan,Bryce W Q Tan,Valentina Tibollo,Patric Tippman,Guillaume Verdy,William Yuan,Paul Avillach,Nils Gehlenborg,Gilbert S Omenn,Consortium for Clinical Characterization of COVID-19 by EHR (4CE),Shyam Visweswaran,Tianxi Cai,Yuan Luo,Zongqi Xia
DOI: https://doi.org/10.1371/journal.pdig.0000484
2024-04-15
Abstract:Few studies examining the patient outcomes of concurrent neurological manifestations during acute COVID-19 leveraged multinational cohorts of adults and children or distinguished between central and peripheral nervous system (CNS vs. PNS) involvement. Using a federated multinational network in which local clinicians and informatics experts curated the electronic health records data, we evaluated the risk of prolonged hospitalization and mortality in hospitalized COVID-19 patients from 21 healthcare systems across 7 countries. For adults, we used a federated learning approach whereby we ran Cox proportional hazard models locally at each healthcare system and performed a meta-analysis on the aggregated results to estimate the overall risk of adverse outcomes across our geographically diverse populations. For children, we reported descriptive statistics separately due to their low frequency of neurological involvement and poor outcomes. Among the 106,229 hospitalized COVID-19 patients (104,031 patients ≥18 years; 2,198 patients <18 years, January 2020-October 2021), 15,101 (14%) had at least one CNS diagnosis, while 2,788 (3%) had at least one PNS diagnosis. After controlling for demographics and pre-existing conditions, adults with CNS involvement had longer hospital stay (11 versus 6 days) and greater risk of (Hazard Ratio = 1.78) and faster time to death (12 versus 24 days) than patients with no neurological condition (NNC) during acute COVID-19 hospitalization. Adults with PNS involvement also had longer hospital stay but lower risk of mortality than the NNC group. Although children had a low frequency of neurological involvement during COVID-19 hospitalization, a substantially higher proportion of children with CNS involvement died compared to those with NNC (6% vs 1%). Overall, patients with concurrent CNS manifestation during acute COVID-19 hospitalization faced greater risks for adverse clinical outcomes than patients without any neurological diagnosis. Our global informatics framework using a federated approach (versus a centralized data collection approach) has utility for clinical discovery beyond COVID-19.